JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 18, 2006; DOI: 10.1124/jpet.106.104414


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104414v1
318/1/381    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCallum, S.
Right arrow Articles by Quik, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCallum, S.
Right arrow Articles by Quik, M.


Received for publication March 13, 2006.
Revised April 17, 2006.
Accepted for publication April 17, 2006.

Differential regulation of mesolimbic {alpha}3*/{alpha}6{beta}2* and {alpha}4{beta}2* nAChR sites and function after long-term oral nicotine to monkeys

Sarah McCallum 1, Neeraja Parameswaran 2, Tanuja Bordia 2, Hong Fan 3, Michael McIntosh 4, Maryka Quik 2*

1 Albany Medical College 2 The Parkinson's Institute 3 Johns Hopkins University School of Medicine 4 University of Utan

* Address correspondence to: E-mail: mquik{at}parkinsonsinstitute.org

Abstract

Since the mesolimbic dopamine system plays a critical role in nicotine addiction/reinforcement and since nicotinic receptors regulate dopamine release, we initiated a study to evaluate the long-term effects of nicotine (>6 months at the final dose) on nicotinic receptor (nAChR) sites and function in the nucleus accumbens of nonhuman primates. Nicotine was given in the drinking water as this mode of administration is long-term but intermittent, thus resembling smoking in this aspect. We determined the effects of nicotine treatment on function and binding of the {alpha}3/{alpha}6{beta}2* and {alpha}4{beta}2* nAChRs subtypes in nucleus accumbens, a region directly implicated in the addictive effects of nicotine. To evaluate function, we measured nicotine and K+-evoked 3H-dopamine release from nucleus accumbens synaptosomes. Changes in {alpha}4{beta}2* and {alpha}3/{alpha}6{beta}2* nAChRs were measured using 125I-epibatidine, 125I-A85380 and 125I-{alpha}-conotoxinMII autoradiography. Chronic nicotine treatment, which led to plasma nicotine levels in the range of smokers, significantly increased nucleus accumbens {alpha}4{beta}2* nAChR sites and function compared to control. By contrast, this treatment did not significantly change {alpha}3/{alpha}6{beta}2* nAChR sites or evoked dopamine release in this region compared to control. These data are thus distinct from previous results in striatum in which the same nicotine treatment paradigm decreased striatal {alpha}3/{alpha}6{beta}2* nAChR sites and function. The finding that long-term nicotine treatment selectively modulates {alpha}4{beta}2*, and not {alpha}3/{alpha}6{beta}2*, nAChR expression in primate nucleus accumbens, is consistent with the results of studies in nicotinic receptor mutant mice implicating the {alpha}4{beta}2* nAChR subtype in nicotine-mediated addiction.


Key words: Nicotinic, alpha-conotoxinMII, mesolimbic, nicotine, nonhuman primates, nucleus accumbens


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar
Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.